Lifebit R.E.A.L.: Real-Time Adverse Drug Reaction Surveillance

Real-Time Adverse Drug Reaction Surveillance Platform

Automated ADR Signal Detection for Real-Time Pharmacovigilance

Lifebit’s platform sets a new standard in real-time adverse drug reaction surveillance, empowering regulatory and research bodies with immediate insights.

Trusted by the world's biomedical leaders

Smarter pharmacovigilance for public health and safety

Lifebit R.E.A.L. turns global real-world data into instant insights—automatically detecting adverse drug reactions (ADRs), surfacing trends, and prioritizing risks without delays.

Eliminate manual review
Reduce costs
Prioritize security
Safeguard patients

Your trusted partner for real-time pharmacovigilance

Powering trusted ADR insights for the world’s leading public health agencies and pharma innovators.

AI-powered signal detection at scale

Detect emerging adverse drug reactions (ADRs) in real time using AI-driven analysis of global structured and unstructured data—minimizing manual review delays.

Built for regulatory compliance and speed

Fully compliant with FedRAMP, HIPAA, GDPR, and FDA guidelines, Lifebit R.E.A.L. delivers secure, real-time surveillance across health and research ecosystems.

Trusted by governments and global leaders

Selected by NIH, Singapore’s Ministry of Health, and Boehringer Ingelheim, Lifebit R.E.A.L. powers scalable ADR monitoring and safety insights worldwide.

Impact

Accelerate signal detection and optimize post-market safety monitoring with Lifebit R.E.A.L.™

Lower Surveillance Costs

Up to 30%

savings with federated compute, cloud resource optimization, and intelligent cost governance.

AI-Powered Detection

< 24 hours

to detect new adverse events using federated AI across structured and unstructured data sources.

Compliant Reproducibility

100%

traceability across case clustering, model-based signal evaluation, and exportable reports with full audit trails.

How it Works.

We’ve outlined how Lifebit R.E.A.L.™ helps organizations unlock real-time adverse event insights from complex, distributed data—securely and at scale.

Log in and define your safety focus.

Start by accessing the Lifebit R.E.A.L.™ platform. Simply specify the drug(s), therapeutic class, population, or event type you wish to monitor. The system instantly configures real-time surveillance parameters—no code or setup needed.

Track emerging risks, instantly.

The platform continuously scans global data—clinical notes, public health records, and spontaneous reporting systems—to surface real-time adverse drug reactions (ADRs) across populations and geographies.

Detect ADR signals in real-time

Lifebit continuously monitors global data sources—from EHRs and safety databases to literature and social media—for emerging adverse drug reactions (ADRs), keeping you ahead of potential threats.

Visualize activity and signal clusters

Interactive dashboards display geographic case maps, spike alerts, and granular case-level data with intuitive filters by drug, demographic, region, or clinical outcome—enabling instant signal tracking, risk assessment, and proactive action planning.

Prioritize and triage emerging ADRs

AI models rank signals by severity, frequency, and novelty—so you know what matters most. Drill into timelines, supporting evidence, and affected populations to support faster decisions.

Generate reports and share insights

Export datasets, download trend visualizations, and create summary PDFs. Lifebit R.E.A.L.™ supports regulatory reporting and internal reviews—backed by full data lineage and audit trails.

Frequently asked questions

What is Lifebit R.E.A.L.™?

How does Lifebit R.E.A.L.™ support ADR surveillance?

R.E.A.L.™ continuously monitors diverse data sources, including clinical records and external media, to identify safety signals. It surfaces geographic spikes, case clusters, and risk trends via intuitive dashboards and alerts.

Who is Lifebit R.E.A.L.™ designed for?

What data sources does R.E.A.L.™ use for ADR detection?

Can I use my own models or tools within the platform?

How quickly can Lifebit R.E.A.L.™ be deployed?

Is Lifebit R.E.A.L.™ compliant with data protection standards?

How does Lifebit R.E.A.L.™ differ from traditional pharmacovigilance tools?

Ready to collaborate on distributed data?

Contact Lifebit today and discover how our federated data solutions can accelerate your research.

We’ll respond as soon as possible.